Pharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-effect
models, and model evaluation should be an important part of the analysis. Recently, …

Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a
clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the …

The characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …

… overall French clinical cohort assessing patients with COVID-19 (NCT04262921). All patients
at French hospitals who were diagnosed with COVID-19 according to the French National …

Background Interpretation of the evidence from randomised controlled trials (RCTs) of
remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the …

Abstract Model evaluation is an important issue in population analyses. We aimed to perform
a systematic review of all population pharmacokinetic and/or pharmacodynamic analyses …

Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

Background Ebola virus disease (EVD) is a highly lethal condition for which no specific
treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the …

… In France, the incidence is estimated to be at least 30 per 100,000 persons per year, and
the mean age at diagnosis of SCCS is 74 years in males and 77 years in females.Most …

Purpose The aim of this study is to define and illustrate metrics for the external evaluation of
a population model. Materials and Methods In this paper, several types of metrics are defined…